State CT
Clinical Trials in Connecticut
Recruiting clinical trials with at least one study location in Connecticut. Data updated daily from ClinicalTrials.gov.
Top Conditions in Connecticut
Frequently Asked Questions — Clinical Trials in Connecticut
How many clinical trials are currently recruiting in Connecticut?
ClinicalMetric currently tracks 201 actively recruiting clinical trials with at least one location in Connecticut. The total number of registered studies—including active but not currently enrolling trials—is 201. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Connecticut?
Connecticut hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Alcohol Use Disorder, Advanced Solid Tumors, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Connecticut serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Connecticut?
To join a clinical trial in Connecticut, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Connecticut maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Connecticut
NCT06480383 Phase 2
Recruiting
Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiet...
Condition
Generalized Anxiety Disorder
Enrollment
705 pts
Location
United States, Bulgaria, Czechia
Sponsor
Intra-Cellular Therapies, Inc.
NCT05264779 N/A
Recruiting
The Periviable GOALS Decision Support Tool
Condition
Pregnancy Preterm
Enrollment
300 pts
Location
United States
Sponsor
Indiana University
NCT07293260 Phase 3
Recruiting
Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronar...
Condition
Cardiovascular Disease
Enrollment
406 pts
Location
United States, Australia, Canada
Sponsor
Amgen
NCT06596473 Phase 1
Recruiting
A Study of BG-C477 in Participants With Advanced Solid Tumors
Condition
Advanced Solid Tumors
Enrollment
310 pts
Location
United States, Australia, China
Sponsor
BeOne Medicines
NCT02000089 Phase 3
Recruiting
The Cancer of the Pancreas Screening-5 CAPS5)Study
Condition
Pancreas Cancer
Enrollment
9,000 pts
Location
United States
Sponsor
Johns Hopkins University
NCT05555589 Phase 3
Recruiting
Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for th...
Condition
Neurotrophic Keratopathy
Enrollment
70 pts
Location
United States, Italy, Poland
Sponsor
ReGenTree, LLC
NCT07142356 Phase 2
Recruiting
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
Condition
Uncontrolled Hypertension
Enrollment
280 pts
Location
United States
Sponsor
Retension Pharmaceuticals. Inc
NCT05303519 Phase 3
Recruiting
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Condition
Glioma
Enrollment
365 pts
Location
United States, Australia, China
Sponsor
Nuvation Bio Inc.
NCT05907629 N/A
Recruiting
Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vasc...
Condition
Stroke
Enrollment
300 pts
Location
United States
Sponsor
Yale University
NCT04406831 N/A
Recruiting
The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pa...
Condition
Pancreatic Cancer Stage III
Enrollment
200 pts
Location
United States
Sponsor
Nuvance Health
NCT05397639 Phase 3
Recruiting
Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type
Condition
Agitation
Enrollment
375 pts
Location
United States, Croatia, Poland
Sponsor
Suven Life Sciences Limited
NCT05042102 Phase 2
Recruiting
Donepezil and Cognitive Training for Alcohol Use Disorder (AUD)
Condition
Alcohol Use Disorder
Enrollment
160 pts
Location
United States
Sponsor
VA Connecticut Healthcare Syst
NCT05428735 N/A
Recruiting
The DRAGON 2 Trial
Condition
Colorectal Cancer Liver Metastases (CRLM)
Enrollment
348 pts
Location
United States, Australia, Austria
Sponsor
Maastricht University
NCT06735833 N/A
Recruiting
MMA Embolization for Refractory Chronic Migraine
Condition
Migraine
Enrollment
70 pts
Location
United States
Sponsor
Cerenovus, Part of DePuy Synth
NCT06188585 N/A
Recruiting
Randomized Trial of UI-EWD vs. Conventional Endoscopic Therapy for Nonvariceal U...
Condition
Acute Gastrointestinal Bleeding
Enrollment
278 pts
Location
United States, Canada, Denmark
Sponsor
Medtronic - MITG
NCT02986984 N/A
Recruiting
Transformative Research in Diabetic Nephropathy
Condition
Diabetic Nephropathies
Enrollment
400 pts
Location
United States
Sponsor
University of Pennsylvania
NCT05869955 Phase 1
Recruiting
A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Seve...
Condition
Systemic Lupus Erythematosus
Enrollment
270 pts
Location
United States, Belgium, France
Sponsor
Juno Therapeutics, Inc., a Bri
NCT05317455 EARLY_Phase 1
Recruiting
Regulation of Brain Glucose Metabolism in Type 1 Diabetes
Condition
Diabetes Mellitus, Type 1
Enrollment
16 pts
Location
United States
Sponsor
Yale University
NCT05683184 Phase 1
Recruiting
OMAR Opioid Use Disorder
Condition
Healthy Control
Enrollment
30 pts
Location
United States
Sponsor
Yale University
NCT06880055 N/A
Recruiting
Shield Post-Approval Study Protocol
Condition
Colo-rectal Cancer
Enrollment
3,375 pts
Location
United States
Sponsor
Guardant Health, Inc.
NCT06668194 N/A
Recruiting
Effect of Force Magnitude on Canine Retraction and Gingival Crevicular Fluid Pro...
Condition
Tooth Crowding
Enrollment
40 pts
Location
United States
Sponsor
UConn Health
NCT04174157 N/A
Recruiting
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Condition
Spinal Muscular Atrophy (SMA)
Enrollment
700 pts
Location
United States, Greece, Ireland
Sponsor
Novartis Pharmaceuticals
NCT06649812 Phase 2
Recruiting
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients...
Condition
High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements
Enrollment
120 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT05904028 Phase 3
Recruiting
Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascu...
Condition
Neovascular Age-related Macular Degeneration
Enrollment
600 pts
Location
United States, Canada
Sponsor
Jaeb Center for Health Researc
NCT07000357 Phase 3
Recruiting
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a Histo...
Condition
Cardiovascular Disease
Enrollment
15,100 pts
Location
United States, Argentina, Brazil
Sponsor
AstraZeneca
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology